Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis

INTRODUCTION: Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However, DAPT duration is a concern in high bleeding risk (HBR) patients. We evaluated the effect of short DAPT (1–3 months) comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bainey, Kevin R., Marquis-Gravel, Guillaume, MacDonald, Blair J., Bewick, David, Yan, Andrew, Turgeon, Ricky D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473507/
https://www.ncbi.nlm.nih.gov/pubmed/37656721
http://dx.doi.org/10.1371/journal.pone.0291061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473507/
https://www.ncbi.nlm.nih.gov/pubmed/37656721
http://dx.doi.org/10.1371/journal.pone.0291061

Ejemplares similares